Therapeutic drug monitoring: standardization of Promonitor Quick IFX and Promonitor Quick ADL point of care tests with WHO International Standards for the quantification of infliximab and adalimumab in whole blood and serum

被引：0

|

作者：

Ametzazurra, A. ^{[1
]}

Pascual, J. ^{[1
]}

Del Rio, L. ^{[1
]}

Urigoitia, A. ^{[1
]}

Nagore, D. ^{[1
]}

Ruiz-Arguello, M. B. ^{[1
]}

机构：

[1] Progenika Biopharma Grifols, Res & Dev, Derio, Spain

来源：

JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P337

引用

下载

收藏

页码：I353 / I354

页数：2

相关论文

共 3 条

[1] THERAPEUTIC DRUG MONITORING: STANDARDIZATION OF PROMONITOR QUICK IFX AND PROMONITOR QUICK ADL POINT OF CARE TESTS WITH WHO INTERNATIONAL STANDARDS FOR THE QUANTIFICATION OF INFLIXIMAB AND ADALIMUMAB IN WHOLE BLOOD AND SERUM
Ametzazurra, A.
Pascual, J.
Del Rio, L.
Urigoitia, A.
Nagore, D.
Ruiz-Arguello, M. B.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1304 - 1305
[2] Therapeutic drug monitoring: standardization of Promonitor Quick IFX and Promonitor Quick ADL point of care tests with WHO International Standards for the quantification of infliximab and adalimumab in whole blood and serum
Ametzazurra, A.
Pascual, J.
Del Rio, L.
Urigoitia, A.
Nagore, D.
Ruiz-Arguello, M. B.
JOURNAL OF CROHNS & COLITIS, 2022, 16 : I353 - I354
[3] Fluorescence-polarization immunoassays within glass fiber micro-chambers enable tobramycin quantification in whole blood for therapeutic drug monitoring at the point of care
Bojescu, E. -Diana
Prim, Denis
Pfeifer, Marc E.
Segura, Jean-Manuel
ANALYTICA CHIMICA ACTA, 2022, 1225